As advised via PHARMAC tender of 30 April 2018 there is to be a change in the listing and future sole supply.

New listing from 1 November 2018 (HML only)

Ketalar Pfizer Inj 100 mg per ml, 2 ml vial, 5 vial                                               Pharmacode 436895                   Schedule price $31.50

Incumbent brand

Ketamine-Claris AFT Inj 100 mg per ml, 2 ml ampoule, 5 ampoules                   Pharmacode 2471272       Schedule price $47.05

Reference pricing will not apply to the incumbent which will be delisted 1 January 2019.

As of the date of this notification ProPharma / PWR cannot accept Ketamine-Claris for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

Once again we need your support to ensure stock in the supply chain moves through to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author